Cargando…

Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis

BACKGROUND: This study will evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) to investigate tumor resectability at primary debulking surgery among women experiencing advanced-stage ovarian cancer. METHODS: We will systematically search the randomized controlled trials (RCTs) for...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ping, Deng, Lingli, Yang, Lijun, Yuan, Xianhong, Xia, Wei, Su, Yongxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738068/
https://www.ncbi.nlm.nih.gov/pubmed/33327269
http://dx.doi.org/10.1097/MD.0000000000023419
_version_ 1783623053171752960
author Liu, Ping
Deng, Lingli
Yang, Lijun
Yuan, Xianhong
Xia, Wei
Su, Yongxue
author_facet Liu, Ping
Deng, Lingli
Yang, Lijun
Yuan, Xianhong
Xia, Wei
Su, Yongxue
author_sort Liu, Ping
collection PubMed
description BACKGROUND: This study will evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) to investigate tumor resectability at primary debulking surgery among women experiencing advanced-stage ovarian cancer. METHODS: We will systematically search the randomized controlled trials (RCTs) for potentially eligible studies from electronic databases, including 4 English databases (PubMed, EMBASE, Web of Science, and Cochrane Library) and 3 Chinese databases (China National Knowledge Infrastructure, WanFang, and China Biomedical Database). The study language will be restricted to English and Chinese. Also, 2 independent authors will collect and carry out data extraction as well as quality assessment. Data will be synthesized using appropriate statistical methods. RESULTS: We will summarize present study's evidence to assess the diagnostic accuracy of MRI for evaluating tumor resectability at primary debulking surgery in women experiencing advanced-stage ovarian cancer. CONCLUSION: The present study will put forward the latest high-quality evidence for MRI's clinical application for evaluating tumor resectability in women experiencing advanced ovarian cancer. ETHICS AND DISSEMINATION: Since the present study is a systematic review and meta-analysis based on the published literature, ethical approval will not be necessary. PROTOCOL REGISTRATION NUMBER: DOI 10.17605/OSF.IO/UWDRF (https://osf.io/uwdrf/)
format Online
Article
Text
id pubmed-7738068
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77380682020-12-16 Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis Liu, Ping Deng, Lingli Yang, Lijun Yuan, Xianhong Xia, Wei Su, Yongxue Medicine (Baltimore) 3700 BACKGROUND: This study will evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) to investigate tumor resectability at primary debulking surgery among women experiencing advanced-stage ovarian cancer. METHODS: We will systematically search the randomized controlled trials (RCTs) for potentially eligible studies from electronic databases, including 4 English databases (PubMed, EMBASE, Web of Science, and Cochrane Library) and 3 Chinese databases (China National Knowledge Infrastructure, WanFang, and China Biomedical Database). The study language will be restricted to English and Chinese. Also, 2 independent authors will collect and carry out data extraction as well as quality assessment. Data will be synthesized using appropriate statistical methods. RESULTS: We will summarize present study's evidence to assess the diagnostic accuracy of MRI for evaluating tumor resectability at primary debulking surgery in women experiencing advanced-stage ovarian cancer. CONCLUSION: The present study will put forward the latest high-quality evidence for MRI's clinical application for evaluating tumor resectability in women experiencing advanced ovarian cancer. ETHICS AND DISSEMINATION: Since the present study is a systematic review and meta-analysis based on the published literature, ethical approval will not be necessary. PROTOCOL REGISTRATION NUMBER: DOI 10.17605/OSF.IO/UWDRF (https://osf.io/uwdrf/) Lippincott Williams & Wilkins 2020-12-11 /pmc/articles/PMC7738068/ /pubmed/33327269 http://dx.doi.org/10.1097/MD.0000000000023419 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3700
Liu, Ping
Deng, Lingli
Yang, Lijun
Yuan, Xianhong
Xia, Wei
Su, Yongxue
Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis
title Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis
title_full Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis
title_fullStr Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis
title_full_unstemmed Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis
title_short Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic review and meta-analysis
title_sort magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: a protocol for systematic review and meta-analysis
topic 3700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738068/
https://www.ncbi.nlm.nih.gov/pubmed/33327269
http://dx.doi.org/10.1097/MD.0000000000023419
work_keys_str_mv AT liuping magneticresonanceimagingforevaluatingtumorresectabilityinadvancedovariancanceraprotocolforsystematicreviewandmetaanalysis
AT denglingli magneticresonanceimagingforevaluatingtumorresectabilityinadvancedovariancanceraprotocolforsystematicreviewandmetaanalysis
AT yanglijun magneticresonanceimagingforevaluatingtumorresectabilityinadvancedovariancanceraprotocolforsystematicreviewandmetaanalysis
AT yuanxianhong magneticresonanceimagingforevaluatingtumorresectabilityinadvancedovariancanceraprotocolforsystematicreviewandmetaanalysis
AT xiawei magneticresonanceimagingforevaluatingtumorresectabilityinadvancedovariancanceraprotocolforsystematicreviewandmetaanalysis
AT suyongxue magneticresonanceimagingforevaluatingtumorresectabilityinadvancedovariancanceraprotocolforsystematicreviewandmetaanalysis